Breaking News

Over a quarter ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Conference/Events
Cowen to hold a conference » 04:55
11/13/19
11/13
04:55
11/13/19
04:55
ABAHF

Abacus Health Products

$0.00 /

+ (+0.00%)

, ACB

Aurora Cannabis

$3.56 /

-0.05 (-1.39%)

, CL

Colgate-Palmolive

$66.65 /

+0.11 (+0.17%)

, CRON

Cronos Group

$7.83 /

-0.25 (-3.09%)

, CVSI

CV Sciences

$0.00 /

+ (+0.00%)

, EMBI

Emergent Biosolutions

$0.00 /

+ (+0.00%)

, GTI

Symbol now EAF

$0.00 /

+ (+0.00%)

, HEXO

Hexo

$2.13 /

-0.005 (-0.23%)

, IMLFF

InMed Pharmaceuticals

$0.00 /

+ (+0.00%)

, NEPT

Neptune Wellness

$3.10 /

+0.15 (+5.08%)

, OGI

Organigram

$2.71 /

-0.67 (-19.82%)

, PKI

PerkinElmer

$87.89 /

+0.39 (+0.45%)

, RIV

Riviera Holdings

$16.25 /

-0.05 (-0.31%)

, SNDL

Sundial Growers

$3.78 /

-0.07 (-1.82%)

, TILT

Symbol TLLTF

$121.95 /

+ (+0.00%)

, TLRY

Tilray

$21.57 /

-0.4 (-1.82%)

, TPB

Turning Point Brands

$26.31 /

+0.52 (+2.02%)

, XLY

Consumer Discretionary Sector SPDR

$121.00 /

-0.06 (-0.05%)

, ZYNE

Zynerba

$6.53 /

-0.27 (-3.97%)

2nd Annual Boston…

2nd Annual Boston Cannabis Conference will be held in Boston on November 12-13.

ShowHide Related Items >><<
ABAHF Abacus Health Products
$0.00 /

+ (+0.00%)

ACB Aurora Cannabis
$3.56 /

-0.05 (-1.39%)

11/11/19 MKM Partners
Canopy Growth, Aurora Cannabis price targets lowered at MKM Partners
11/05/19 BofA
BofA says Mexico cannabis legalization 'still in play' in 2020 after extension
11/05/19 Cantor Fitzgerald
Aurora Cannabis initiated with a Neutral at Cantor Fitzgerald
11/04/19 Cantor Fitzgerald
Aurora Cannabis initiated with a Neutral at Cantor Fitzgerald
CL Colgate-Palmolive
$66.65 /

+0.11 (+0.17%)

10/16/19 Berenberg
Colgate-Palmolive re-initiated with a Sell at Berenberg
09/11/19 Morgan Stanley
Clorox valuation unwarranted given widening gap with peers, says Morgan Stanley
06/11/19 Argus
Colgate-Palmolive price target raised to $82 from $72 at Argus
04/29/19
Fly Intel: Top five analyst upgrades
CRON Cronos Group
$7.83 /

-0.25 (-3.09%)

10/22/19 Piper Sandler
Piper cuts targets in Cannabis, says Canopy and Cronos best positioned
10/18/19 Stifel
Cronos Group upgraded to Buy from Hold at Stifel
10/16/19 BofA
BofA lowers cannabis stock price targets on further sales estimate changes
CVSI CV Sciences
$0.00 /

+ (+0.00%)

11/07/19 Cantor Fitzgerald
Cantor Fitzgerald expects industry consolidation in consumer CBD wellness trend
11/07/19 Cantor Fitzgerald
CV Sciences initiated with an Overweight at Cantor Fitzgerald
11/07/19 Cantor Fitzgerald
CV Sciences initiated with an Overweight at Cantor Fitzgerald
EMBI Emergent Biosolutions
$0.00 /

+ (+0.00%)

GTI Symbol now EAF
$0.00 /

+ (+0.00%)

HEXO Hexo
$2.13 /

-0.005 (-0.23%)

11/05/19 Cantor Fitzgerald
Hexo initiated with an Underweight at Cantor Fitzgerald
10/30/19 Eight Capital
Hexo downgraded to Sell from Neutral at Eight Capital
10/30/19 Canaccord
Hexo downgraded to Hold from Speculative Buy at Canaccord
10/29/19 Roth Capital
Hexo price target cut to $2.50 from $3 at Roth Capital
IMLFF InMed Pharmaceuticals
$0.00 /

+ (+0.00%)

03/15/19 Roth Capital
InMed Pharmaceuticals initiated with a Buy at Roth Capital
NEPT Neptune Wellness
$3.10 /

+0.15 (+5.08%)

04/09/19
Neptune Wellness initiated with a Buy at GMP Securities
OGI Organigram
$2.71 /

-0.67 (-19.82%)

11/12/19 BMO Capital
Organigram downgraded to Market Perform from Outperform at BMO Capital
11/05/19 Cantor Fitzgerald
Organigram initiated with an Overweight at Cantor Fitzgerald
10/11/19 Jefferies
Organigram upgraded to Buy on overdone selloff at Jefferies
10/11/19 Jefferies
Organigram upgraded to Buy from Hold at Jefferies
PKI PerkinElmer
$87.89 /

+0.39 (+0.45%)

10/31/19 Piper Sandler
PerkinElmer downgraded to Neutral from Overweight at Piper Jaffray
10/08/19 Cleveland Research
Cleveland sees 'noticeable' slowdown in Life Science equipment demand
09/26/19 BofA
Bruker, PerkinElmer, Personalis upgraded to Buy at BofA/Merrill
09/26/19 BofA
PerkinElmer upgraded to Buy from Neutral at BofA/Merrill
RIV Riviera Holdings
$16.25 /

-0.05 (-0.31%)

SNDL Sundial Growers
$3.78 /

-0.07 (-1.82%)

10/31/19 BMO Capital
BMO downgrades Sundial Growers to Market Perform on lower cannabis demand
10/30/19 BMO Capital
Sundial Growers downgraded to Market Perform from Outperform at BMO Capital
09/27/19 Barclays
Sundial Growers initiated with an Overweight at Barclays
09/10/19 BMO Capital
BMO upgrades Sundial Growers to Outperform after share decline
TILT Symbol TLLTF
$121.95 /

+ (+0.00%)

TLRY Tilray
$21.57 /

-0.4 (-1.82%)

11/05/19 Cantor Fitzgerald
Tilray initiated with a Neutral at Cantor Fitzgerald
11/04/19 Cantor Fitzgerald
Tilray initiated with a Neutral at Cantor Fitzgerald
10/25/19 Jefferies
Tilray clinical trial update yesterday a positive, says Jefferies
TPB Turning Point Brands
$26.31 /

+0.52 (+2.02%)

09/20/19 B. Riley FBR
Turning Point trades at 34% discount to core segments, says B. Riley FBR
03/12/19 B. Riley FBR
Turning Point Brands price target raised to $55 from $45 at B. Riley FBR
XLY Consumer Discretionary Sector SPDR
$121.00 /

-0.06 (-0.05%)

ZYNE Zynerba
$6.53 /

-0.27 (-3.97%)

10/21/19 Needham
Zynerba initiated with a Buy at Needham
10/10/19 Stifel
Hexo miss further damages cannabis industry credibility, says Stifel
09/19/19 H.C. Wainwright
Zynerba selloff on open-label data for Zygel 'unwarranted,' says H.C. Wainwright
09/19/19 Canaccord
Zynerba data confusion creates buying opportunity, says Canaccord
Conference/Events
Cowen to hold a conference » 08:40
11/12/19
11/12
08:40
11/12/19
08:40
ABAHF

Abacus Health Products

$0.00 /

+ (+0.00%)

, ACB

Aurora Cannabis

$3.61 /

-0.195 (-5.12%)

, CL

Colgate-Palmolive

$66.54 /

-0.08 (-0.12%)

, CRON

Cronos Group

$8.08 /

-0.435 (-5.11%)

, CVSI

CV Sciences

$0.00 /

+ (+0.00%)

, EMBI

Emergent Biosolutions

$0.00 /

+ (+0.00%)

, GTI

Symbol now EAF

$0.00 /

+ (+0.00%)

, HEXO

Hexo

$2.13 /

-0.22 (-9.36%)

, IMLFF

InMed Pharmaceuticals

$0.00 /

+ (+0.00%)

, NEPT

Neptune Wellness

$2.95 /

-0.61 (-17.13%)

, OGI

Organigram

$3.38 /

-0.28 (-7.65%)

, PKI

PerkinElmer

$87.50 /

+0.18 (+0.21%)

, RIV

Riviera Holdings

$16.30 /

-0.04 (-0.24%)

, SNDL

Sundial Growers

$3.85 /

+0.08 (+2.12%)

, TILT

Symbol TLLTF

$121.95 /

+ (+0.00%)

, TLRY

Tilray

$21.97 /

-1.49 (-6.35%)

, TPB

Turning Point Brands

$25.79 /

-0.92 (-3.44%)

, XLY

Consumer Discretionary Sector SPDR

$121.06 /

-0.27 (-0.22%)

, ZYNE

Zynerba

$6.80 /

+0.36 (+5.59%)

2nd Annual Boston…

2nd Annual Boston Cannabis Conference will be held in Boston on November 12-13.

ShowHide Related Items >><<
ABAHF Abacus Health Products
$0.00 /

+ (+0.00%)

ACB Aurora Cannabis
$3.61 /

-0.195 (-5.12%)

11/11/19 MKM Partners
Canopy Growth, Aurora Cannabis price targets lowered at MKM Partners
11/05/19 BofA
BofA says Mexico cannabis legalization 'still in play' in 2020 after extension
11/05/19 Cantor Fitzgerald
Aurora Cannabis initiated with a Neutral at Cantor Fitzgerald
11/04/19 Cantor Fitzgerald
Aurora Cannabis initiated with a Neutral at Cantor Fitzgerald
CL Colgate-Palmolive
$66.54 /

-0.08 (-0.12%)

10/16/19 Berenberg
Colgate-Palmolive re-initiated with a Sell at Berenberg
09/11/19 Morgan Stanley
Clorox valuation unwarranted given widening gap with peers, says Morgan Stanley
06/11/19 Argus
Colgate-Palmolive price target raised to $82 from $72 at Argus
04/29/19
Fly Intel: Top five analyst upgrades
CRON Cronos Group
$8.08 /

-0.435 (-5.11%)

10/22/19 Piper Sandler
Piper cuts targets in Cannabis, says Canopy and Cronos best positioned
10/18/19 Stifel
Cronos Group upgraded to Buy from Hold at Stifel
10/16/19 BofA
BofA lowers cannabis stock price targets on further sales estimate changes
CVSI CV Sciences
$0.00 /

+ (+0.00%)

11/07/19 Cantor Fitzgerald
Cantor Fitzgerald expects industry consolidation in consumer CBD wellness trend
11/07/19 Cantor Fitzgerald
CV Sciences initiated with an Overweight at Cantor Fitzgerald
11/07/19 Cantor Fitzgerald
CV Sciences initiated with an Overweight at Cantor Fitzgerald
EMBI Emergent Biosolutions
$0.00 /

+ (+0.00%)

GTI Symbol now EAF
$0.00 /

+ (+0.00%)

HEXO Hexo
$2.13 /

-0.22 (-9.36%)

11/05/19 Cantor Fitzgerald
Hexo initiated with an Underweight at Cantor Fitzgerald
10/30/19 Eight Capital
Hexo downgraded to Sell from Neutral at Eight Capital
10/30/19 Canaccord
Hexo downgraded to Hold from Speculative Buy at Canaccord
10/29/19 Roth Capital
Hexo price target cut to $2.50 from $3 at Roth Capital
IMLFF InMed Pharmaceuticals
$0.00 /

+ (+0.00%)

03/15/19 Roth Capital
InMed Pharmaceuticals initiated with a Buy at Roth Capital
NEPT Neptune Wellness
$2.95 /

-0.61 (-17.13%)

04/09/19
Neptune Wellness initiated with a Buy at GMP Securities
OGI Organigram
$3.38 /

-0.28 (-7.65%)

11/12/19 BMO Capital
Organigram downgraded to Market Perform from Outperform at BMO Capital
11/05/19 Cantor Fitzgerald
Organigram initiated with an Overweight at Cantor Fitzgerald
10/11/19 Jefferies
Organigram upgraded to Buy on overdone selloff at Jefferies
10/11/19 Jefferies
Organigram upgraded to Buy from Hold at Jefferies
PKI PerkinElmer
$87.50 /

+0.18 (+0.21%)

10/31/19 Piper Sandler
PerkinElmer downgraded to Neutral from Overweight at Piper Jaffray
10/08/19 Cleveland Research
Cleveland sees 'noticeable' slowdown in Life Science equipment demand
09/26/19 BofA
Bruker, PerkinElmer, Personalis upgraded to Buy at BofA/Merrill
09/26/19 BofA
PerkinElmer upgraded to Buy from Neutral at BofA/Merrill
RIV Riviera Holdings
$16.30 /

-0.04 (-0.24%)

SNDL Sundial Growers
$3.85 /

+0.08 (+2.12%)

10/31/19 BMO Capital
BMO downgrades Sundial Growers to Market Perform on lower cannabis demand
10/30/19 BMO Capital
Sundial Growers downgraded to Market Perform from Outperform at BMO Capital
09/27/19 Barclays
Sundial Growers initiated with an Overweight at Barclays
09/10/19 BMO Capital
BMO upgrades Sundial Growers to Outperform after share decline
TILT Symbol TLLTF
$121.95 /

+ (+0.00%)

TLRY Tilray
$21.97 /

-1.49 (-6.35%)

11/05/19 Cantor Fitzgerald
Tilray initiated with a Neutral at Cantor Fitzgerald
11/04/19 Cantor Fitzgerald
Tilray initiated with a Neutral at Cantor Fitzgerald
10/25/19 Jefferies
Tilray clinical trial update yesterday a positive, says Jefferies
TPB Turning Point Brands
$25.79 /

-0.92 (-3.44%)

09/20/19 B. Riley FBR
Turning Point trades at 34% discount to core segments, says B. Riley FBR
03/12/19 B. Riley FBR
Turning Point Brands price target raised to $55 from $45 at B. Riley FBR
XLY Consumer Discretionary Sector SPDR
$121.06 /

-0.27 (-0.22%)

ZYNE Zynerba
$6.80 /

+0.36 (+5.59%)

10/21/19 Needham
Zynerba initiated with a Buy at Needham
10/10/19 Stifel
Hexo miss further damages cannabis industry credibility, says Stifel
09/19/19 H.C. Wainwright
Zynerba selloff on open-label data for Zygel 'unwarranted,' says H.C. Wainwright
09/19/19 Canaccord
Zynerba data confusion creates buying opportunity, says Canaccord
Conference/Events
Hanson Wade to hold a summit » 05:55
09/12/19
09/12
05:55
09/12/19
05:55
EMBI

Emergent Biosolutions

$0.00 /

+ (+0.00%)

2nd Annual International…

2nd Annual International Cannabinoid Derived Pharmaceuticals Summit will be held in Boston on September 10-12.

ShowHide Related Items >><<
Conference/Events
Hanson Wade to hold a summit » 04:55
09/11/19
09/11
04:55
09/11/19
04:55
EMBI

Emergent Biosolutions

$0.00 /

+ (+0.00%)

2nd Annual International…

2nd Annual International Cannabinoid Derived Pharmaceuticals Summit will be held in Boston on September 10-12.

ShowHide Related Items >><<
Conference/Events
Hanson Wade to hold a summit » 08:19
09/10/19
09/10
08:19
09/10/19
08:19
EMBI

Emergent Biosolutions

$0.00 /

+ (+0.00%)

2nd Annual International…

2nd Annual International Cannabinoid Derived Pharmaceuticals Summit will be held in Boston on September 10-12.

ShowHide Related Items >><<
Conference/Events
H.C. Wainwright and Rodman & Renshaw to hold a conference » 04:55
09/10/19
09/10
04:55
09/10/19
04:55
IMV

IMV Inc.

$2.75 /

+ (+0.00%)

, RWLK

ReWalk Robotics

$3.16 /

-0.05 (-1.56%)

, CHRS

Coherus Biosciences

$19.71 /

-0.75 (-3.67%)

, VVUS

VIVUS

$4.03 /

-0.07 (-1.71%)

, ACER

Acer Therapeutics

$2.90 /

+0.07 (+2.47%)

, ATEC

Alphatec

$5.12 /

-0.09 (-1.73%)

, CAPR

Capricor Therapeutics

$2.69 /

+0.04 (+1.51%)

, DRRX

Durect

$1.87 /

+0.08 (+4.47%)

, DRNA

Dicerna

$14.06 /

-0.01 (-0.07%)

, EIGR

Eiger BioPharmaceuticals

$11.19 /

+0.17 (+1.54%)

, CTSO

CytoSorbents

$4.80 /

+0.26 (+5.73%)

, CVM

CEL-SCI

$7.53 /

-0.11 (-1.44%)

, CLSK

CleanSpark

$0.00 /

+ (+0.00%)

, BLDP

Ballard Power

$5.10 /

+0.505 (+10.99%)

, BDSI

BioDelivery Sciences

$4.43 /

+0.03 (+0.68%)

, EMBI

Emergent Biosolutions

$0.00 /

+ (+0.00%)

, HEB

Hemispherx

$0.00 /

+ (+0.00%)

, GTHX

G1 Therapeutics

$36.03 /

-0.18 (-0.50%)

, KALA

Kala Pharmaceuticals

$3.92 /

-0.07 (-1.75%)

, KDMN

Kadmon

$2.51 /

-0.02 (-0.79%)

, MNKD

MannKind

$1.19 /

-0.035 (-2.86%)

, MNLO

Menlo Therapeutics

$5.00 /

+0.23 (+4.82%)

, OPNT

Opiant Pharmaceuticals

$13.60 /

-0.15 (-1.09%)

, PRVB

Provention Bio

$10.13 /

-0.17 (-1.65%)

, SMTS

Sierra Metals

$1.24 /

+0.03 (+2.48%)

, UMRX

Unum Therapeutics

$1.85 /

-0.16 (-7.96%)

, SBBP

Strongbridge Biopharma

$2.77 /

+0.095 (+3.55%)

, PHIO

Phio Pharmaceuticals

$0.31 /

-0.0155 (-4.73%)

, NDRA

Endra Life Sciences

$1.66 /

-0.13 (-7.26%)

, VTVT

vTv Therapeutics

$1.36 /

+0.005 (+0.37%)

, ZYNE

Zynerba

$11.56 /

-0.16 (-1.37%)

, ZYXI

Zynex

$9.00 /

-0.43 (-4.56%)

, VSTM

Verastem

$1.23 /

+ (+0.00%)

, THOR

Synthorx

$18.04 /

-0.85 (-4.50%)

, SAVA

Cassava Sciences

$1.22 /

-0.18 (-12.86%)

21st Annual Healthcare…

21st Annual Healthcare Conference will be held in New York on September 9-10.

ShowHide Related Items >><<
IMV IMV Inc.
$2.75 /

+ (+0.00%)

05/29/19
Fly Intel: Top five analyst initiations
05/29/19 B. Riley FBR
IMV Inc. initiated with a Buy at B. Riley FBR
03/25/19 H.C. Wainwright
IMV Inc. initiated with a Buy at H.C. Wainwright
RWLK ReWalk Robotics
$3.16 /

-0.05 (-1.56%)

06/17/19
Fly Intel: Top five analyst upgrades
06/17/19 H.C. Wainwright
ReWalk Robotics upgraded to Buy from Neutral at H.C. Wainwright
CHRS Coherus Biosciences
$19.71 /

-0.75 (-3.67%)

08/13/19 Mizuho
Coherus Biosciences initiated with a Buy at Mizuho
08/12/19 Barclays
Coherus should be bought on weakness from Enbrel ruling, says Barclays
07/09/19 Barclays
Coherus Biosciences selloff yesterday a buying opportunity, says Barclays
07/08/19 JPMorgan
Coherus selloff unwarranted following Udencya pre-announcement, says JPMorgan
VVUS VIVUS
$4.03 /

-0.07 (-1.71%)

ACER Acer Therapeutics
$2.90 /

+0.07 (+2.47%)

06/26/19 H.C. Wainwright
Acer Therapeutics price target lowered to $10 from $55 at H.C. Wainwright
06/25/19 Roth Capital
Acer Therapeutics price target lowered to $9 from $66 at Roth Capital
06/25/19 Raymond James
Raymond James doesn't see path forward for Edsivo, cuts Acer to Market Perform
06/25/19 Raymond James
Acer Therapeutics downgraded to Market Perform from Outperform at Raymond James
ATEC Alphatec
$5.12 /

-0.09 (-1.73%)

08/28/19
Fly Intel: Top five analyst initiations
08/28/19 Canaccord
Alphatec initiated with a Buy at Canaccord
08/06/19 H.C. Wainwright
Alphatec price target raised to $6 from $4 at H.C. Wainwright
08/05/19
Fly Intel: Top five analyst initiations
CAPR Capricor Therapeutics
$2.69 /

+0.04 (+1.51%)

07/15/19 H.C. Wainwright
Capricor price target raised to $12.40 from $3.50 at H.C. Wainwright
12/31/18 H.C. Wainwright
Capricor price target lowered to $3.50 from $8.60 at H.C. Wainwright
12/26/18 Maxim
Capricor Therapeutics downgraded to Hold from Buy at Maxim
DRRX Durect
$1.87 /

+0.08 (+4.47%)

09/06/19 Cantor Fitzgerald
Durect initiated with an Overweight at Cantor Fitzgerald
07/22/19 H.C. Wainwright
Gilead pact offers validation to Durect technology, says H.C. Wainwright
DRNA Dicerna
$14.06 /

-0.01 (-0.07%)

07/03/19 Citi
Dicerna price target lowered to $25 from $30 at Citi
05/24/19 Citi
Dicerna assumed with a Buy at Citi
05/16/19 Truist
Dicerna price target lowered to $20 from $26 at SunTrust
03/13/19 Truist
Dicerna price target raised to $26 from $20 at SunTrust
EIGR Eiger BioPharmaceuticals
$11.19 /

+0.17 (+1.54%)

06/26/19 Citi
Eiger BioPharmaceuticals initiated with a Buy at Citi
06/18/19 Jefferies
Eiger breakthrough designation a surprise, says Jefferies
04/24/19 Wedbush
Eiger BioPharmaceuticals price target lowered to $35 from $43 at Wedbush
01/29/19
Fly Intel: Top five analyst initiations
CTSO CytoSorbents
$4.80 /

+0.26 (+5.73%)

CVM CEL-SCI
$7.53 /

-0.11 (-1.44%)

CLSK CleanSpark
$0.00 /

+ (+0.00%)

08/27/19
Fly Intel: Top five analyst initiations
08/27/19 H.C. Wainwright
CleanSpark initiated with a Buy at H.C. Wainwright
BLDP Ballard Power
$5.10 /

+0.505 (+10.99%)

07/01/19
Ballard Power downgraded to Sell on valuation at Roth Capital
07/01/19 Roth Capital
Ballard Power downgraded to Sell from Neutral at Roth Capital
11/02/18 B. Riley FBR
Ballard Power downgraded to Neutral from Buy at B. Riley FBR
BDSI BioDelivery Sciences
$4.43 /

+0.03 (+0.68%)

04/16/19 Cantor Fitzgerald
BioDelivery acquisitoin of Symproic a positive, says Cantor Fitzgerald
03/19/19 Truist
BioDelivery Sciences initiated with a Buy at SunTrust
01/31/19
Fly Intel: Top five analyst initiations
01/31/19 Janney Montgomery Scott
BioDelivery Sciences assumed with a Buy at Janney Montgomery Scott
EMBI Emergent Biosolutions
$0.00 /

+ (+0.00%)

HEB Hemispherx
$0.00 /

+ (+0.00%)

08/22/19
Fly Intel: Top five analyst downgrades
08/22/19 Maxim
Hemispherx downgraded to Hold from Buy at Maxim
06/14/19
Fly Intel: Top five analyst initiations
06/14/19 Maxim
Hemispherx initiated with a Buy at Maxim
GTHX G1 Therapeutics
$36.03 /

-0.18 (-0.50%)

08/08/19 JPMorgan
G1 Therapeutics upgraded to Overweight from Neutral at JPMorgan
06/18/19 H.C. Wainwright
G1 Therapeutics trial results 'important,' says H.C. Wainwright
02/07/19 B. Riley FBR
B. Riley FBR starts G1 Therapeutics with Buy rating, $55 price target
02/07/19 B. Riley FBR
G1 Therapeutics initiated with a Buy at B. Riley FBR
KALA Kala Pharmaceuticals
$3.92 /

-0.07 (-1.75%)

06/25/19 Stifel
Evolus can benefit from 'distraction' at Allergan, says Stifel
04/25/19
Oppenheimer initiates Kala with Outperform, sees attractive growth story
04/24/19 Oppenheimer
Kala Pharmaceuticals initiated with an Outperform at Oppenheimer
03/14/19
Fly Intel: Top five analyst initiations
KDMN Kadmon
$2.51 /

-0.02 (-0.79%)

09/06/19 Cantor Fitzgerald
Cantor starts 'under-the-radar' Kadmon with Overweight rating
09/05/19 Cantor Fitzgerald
Kadmon initiated with an Overweight at Cantor Fitzgerald
06/26/19
Fly Intel: Top five analyst initiations
06/26/19
Oppenheimer bullish on Kadmon, initiates with an Outperform
MNKD MannKind
$1.19 /

-0.035 (-2.86%)

05/14/19
Fly Intel: Top five analyst initiations
05/14/19 BTIG
MannKind initiated with a Buy, $3 price target at BTIG
05/08/19 H.C. Wainwright
MannKind price target lowered to $3 from $4 at H.C. Wainwright
03/04/19
Fly Intel: Top five analyst initiations
MNLO Menlo Therapeutics
$5.00 /

+0.23 (+4.82%)

10/09/18 Jefferies
Menlo Therapeutics price target lowered to $7 from $9 at Jefferies
OPNT Opiant Pharmaceuticals
$13.60 /

-0.15 (-1.09%)

05/29/19 Northland
Opiant Pharmaceuticals initiated with an Outperform at Northland
03/22/19 Cantor Fitzgerald
Opiant pipeline remains free at current share levels, says Cantor Fitzgerald
10/26/18
Opiant Pharma initiates patent challenge for Perrigo's generic version of Narcan
09/28/18 Cantor Fitzgerald
Opiant Pharmaceuticals price target raised to $42 from $32 at Cantor Fitzgerald
PRVB Provention Bio
$10.13 /

-0.17 (-1.65%)

08/05/19 SVB Leerink
Provention Bio price target raised to $35 from $17 at SVB Leerink
06/10/19 Chardan
Provention Bio initiated with a Buy at Chardan
02/22/19 SVB Leerink
Provention Bio initiated with an Outperform at SVB Leerink
01/18/19 H.C. Wainwright
Provention Bio initiated with a Buy at H.C. Wainwright
SMTS Sierra Metals
$1.24 /

+0.03 (+2.48%)

UMRX Unum Therapeutics
$1.85 /

-0.16 (-7.96%)

08/13/19 Wedbush
Unum Therapeutics price target lowered to $13 from $20 at Wedbush
07/03/19 H.C. Wainwright
Unum Therapeutics shares overreacted to clinical hold, says H.C. Wainwright
07/03/19 Cowen
Unum Therapeutics clinical hold not an issue, says Cowen
07/03/19 Truist
Unum Therapeutics price target lowered to $6 from $10 at SunTrust
SBBP Strongbridge Biopharma
$2.77 /

+0.095 (+3.55%)

12/18/18 Laidlaw
Strongbridge Biopharma initiated with a Buy at Laidlaw
11/01/18 Stifel
Stifel says Strongbridge makes 'right move' to improve Recorlev clinical package
PHIO Phio Pharmaceuticals
$0.31 /

-0.0155 (-4.73%)

NDRA Endra Life Sciences
$1.66 /

-0.13 (-7.26%)

07/15/19 H.C. Wainwright
Endra Life Sciences initiated with a Buy at H.C. Wainwright
06/13/19
Endra Life Sciences initiated with a Buy at Dougherty
05/20/19 Lake Street
Endra Life Sciences initiated with a Buy at Lake Street
VTVT vTv Therapeutics
$1.36 /

+0.005 (+0.37%)

05/30/19 H.C. Wainwright
vTv Therapeutics initiated with a Buy at H.C. Wainwright
05/06/19 Northland
vTv Therapeutics upgraded to Outperform from Market Perform at Northland
05/06/19 Northland
vTv Therapeutics upgraded to Outperform from Market Perform at Northland
ZYNE Zynerba
$11.56 /

-0.16 (-1.37%)

06/10/19 Piper Sandler
Cannabis regulation could become top 2020 election issue, says Piper Jaffray
05/31/19 Cantor Fitzgerald
Zynerba price target raised to $22 from $12 at Cantor Fitzgerald
05/31/19 H.C. Wainwright
Zynerba remains 'potentially dramatically undervalued,' says H.C. Wainwright
05/08/19
Zynerba reports Q1 EPS (47c), consensus (49c)
ZYXI Zynex
$9.00 /

-0.43 (-4.56%)

06/27/19 B. Riley FBR
Zynex selloff on S-3 filing a buying opportunity, says B. Riley FBR
10/10/18 B. Riley FBR
Zynex initiated with a Buy at B. Riley FBR
VSTM Verastem
$1.23 /

+ (+0.00%)

06/20/19 JonesTrading
JonesTrading downgrades Verastem as CEO marks third major management exit
06/20/19 JonesTrading
Verastem downgraded to Hold from Buy at JonesTrading
06/20/19 BTIG
Verastem downgraded to Neutral from Buy at BTIG
05/14/19 Roth Capital
Verastem price target lowered to $4 from $14 at Roth Capital
THOR Synthorx
$18.04 /

-0.85 (-4.50%)

03/15/19 SVB Leerink
Synthorx initiated with an Outperform at SVB Leerink
01/02/19
Fly Intel: Top five analyst initiations
01/02/19 Jefferies
Jefferies starts Synthorx with Buy rating, $21 price target
01/02/19 H.C. Wainwright
Synthorx initiated with a Buy at H.C. Wainwright
SAVA Cassava Sciences
$1.22 /

-0.18 (-12.86%)

08/01/19
Fly Intel: Top analyst initiations
08/01/19 H.C. Wainwright
Cassava Sciences initiated with a Buy at H.C. Wainwright
06/25/19 Maxim
Cassava Sciences initiated with a Buy at Maxim
06/25/19 Maxim
Cassava Sciences initiated with a Buy at Maxim
Conference/Events
H.C. Wainwright and Rodman & Renshaw to hold a conference » 08:47
09/09/19
09/09
08:47
09/09/19
08:47
IMV

IMV Inc.

$2.75 /

+ (+0.00%)

, RWLK

ReWalk Robotics

$3.21 /

+0.06 (+1.90%)

, CHRS

Coherus Biosciences

$20.46 /

-0.56 (-2.66%)

, VVUS

VIVUS

$4.10 /

-0.01 (-0.24%)

, ACER

Acer Therapeutics

$2.83 /

-0.07 (-2.41%)

, ATEC

Alphatec

$5.21 /

-0.09 (-1.70%)

, CAPR

Capricor Therapeutics

$2.65 /

+0.07 (+2.71%)

, DRRX

Durect

$1.79 /

+0.12 (+7.19%)

, DRNA

Dicerna

$14.07 /

-0.3 (-2.09%)

, EIGR

Eiger BioPharmaceuticals

$11.02 /

+0.01 (+0.09%)

, CTSO

CytoSorbents

$4.54 /

-0.115 (-2.47%)

, CVM

CEL-SCI

$7.64 /

+0.19 (+2.55%)

, CLSK

CleanSpark

$0.00 /

+ (+0.00%)

, BLDP

Ballard Power

$4.60 /

+0.075 (+1.66%)

, BDSI

BioDelivery Sciences

$4.40 /

+ (+0.00%)

, EMBI

Emergent Biosolutions

$0.00 /

+ (+0.00%)

, HEB

Hemispherx

$0.00 /

+ (+0.00%)

, GTHX

G1 Therapeutics

$36.21 /

-0.69 (-1.87%)

, KALA

Kala Pharmaceuticals

$3.99 /

-0.01 (-0.25%)

, KDMN

Kadmon

$2.53 /

+0.05 (+2.02%)

, MNKD

MannKind

$1.23 /

+0.05 (+4.26%)

, MNLO

Menlo Therapeutics

$4.77 /

-0.18 (-3.64%)

, OPNT

Opiant Pharmaceuticals

$13.75 /

-0.04 (-0.29%)

, PRVB

Provention Bio

$10.30 /

+0.31 (+3.10%)

, SMTS

Sierra Metals

$1.21 /

+ (+0.00%)

, UMRX

Unum Therapeutics

$2.01 /

+0.17 (+9.24%)

, SBBP

Strongbridge Biopharma

$2.68 /

+0.055 (+2.10%)

, PHIO

Phio Pharmaceuticals

$0.33 /

+0.0075 (+2.34%)

, NDRA

Endra Life Sciences

$1.79 /

-0.06 (-3.24%)

, VTVT

vTv Therapeutics

$1.35 /

-0.02 (-1.46%)

, ZYNE

Zynerba

$11.72 /

+0.01 (+0.09%)

, ZYXI

Zynex

$9.43 /

-0.05 (-0.53%)

, VSTM

Verastem

$1.23 /

+0.015 (+1.24%)

, THOR

Synthorx

$18.89 /

+0.35 (+1.89%)

, SAVA

Cassava Sciences

$1.40 /

+0.13 (+10.24%)

21st Annual Healthcare…

21st Annual Healthcare Conference will be held in New York on September 9-10.

ShowHide Related Items >><<
IMV IMV Inc.
$2.75 /

+ (+0.00%)

05/29/19
Fly Intel: Top five analyst initiations
05/29/19 B. Riley FBR
IMV Inc. initiated with a Buy at B. Riley FBR
03/25/19 H.C. Wainwright
IMV Inc. initiated with a Buy at H.C. Wainwright
RWLK ReWalk Robotics
$3.21 /

+0.06 (+1.90%)

06/17/19
Fly Intel: Top five analyst upgrades
06/17/19 H.C. Wainwright
ReWalk Robotics upgraded to Buy from Neutral at H.C. Wainwright
CHRS Coherus Biosciences
$20.46 /

-0.56 (-2.66%)

08/13/19 Mizuho
Coherus Biosciences initiated with a Buy at Mizuho
08/12/19 Barclays
Coherus should be bought on weakness from Enbrel ruling, says Barclays
07/09/19 Barclays
Coherus Biosciences selloff yesterday a buying opportunity, says Barclays
07/08/19 JPMorgan
Coherus selloff unwarranted following Udencya pre-announcement, says JPMorgan
VVUS VIVUS
$4.10 /

-0.01 (-0.24%)

ACER Acer Therapeutics
$2.83 /

-0.07 (-2.41%)

06/26/19 H.C. Wainwright
Acer Therapeutics price target lowered to $10 from $55 at H.C. Wainwright
06/25/19 Roth Capital
Acer Therapeutics price target lowered to $9 from $66 at Roth Capital
06/25/19 Raymond James
Raymond James doesn't see path forward for Edsivo, cuts Acer to Market Perform
06/25/19 Raymond James
Acer Therapeutics downgraded to Market Perform from Outperform at Raymond James
ATEC Alphatec
$5.21 /

-0.09 (-1.70%)

08/28/19
Fly Intel: Top five analyst initiations
08/28/19 Canaccord
Alphatec initiated with a Buy at Canaccord
08/06/19 H.C. Wainwright
Alphatec price target raised to $6 from $4 at H.C. Wainwright
08/05/19
Fly Intel: Top five analyst initiations
CAPR Capricor Therapeutics
$2.65 /

+0.07 (+2.71%)

07/15/19 H.C. Wainwright
Capricor price target raised to $12.40 from $3.50 at H.C. Wainwright
12/31/18 H.C. Wainwright
Capricor price target lowered to $3.50 from $8.60 at H.C. Wainwright
12/26/18 Maxim
Capricor Therapeutics downgraded to Hold from Buy at Maxim
DRRX Durect
$1.79 /

+0.12 (+7.19%)

09/06/19 Cantor Fitzgerald
Durect initiated with an Overweight at Cantor Fitzgerald
07/22/19 H.C. Wainwright
Gilead pact offers validation to Durect technology, says H.C. Wainwright
DRNA Dicerna
$14.07 /

-0.3 (-2.09%)

07/03/19 Citi
Dicerna price target lowered to $25 from $30 at Citi
05/24/19 Citi
Dicerna assumed with a Buy at Citi
05/16/19 Truist
Dicerna price target lowered to $20 from $26 at SunTrust
03/13/19 Truist
Dicerna price target raised to $26 from $20 at SunTrust
EIGR Eiger BioPharmaceuticals
$11.02 /

+0.01 (+0.09%)

06/26/19 Citi
Eiger BioPharmaceuticals initiated with a Buy at Citi
06/18/19 Jefferies
Eiger breakthrough designation a surprise, says Jefferies
04/24/19 Wedbush
Eiger BioPharmaceuticals price target lowered to $35 from $43 at Wedbush
01/29/19
Fly Intel: Top five analyst initiations
CTSO CytoSorbents
$4.54 /

-0.115 (-2.47%)

CVM CEL-SCI
$7.64 /

+0.19 (+2.55%)

CLSK CleanSpark
$0.00 /

+ (+0.00%)

08/27/19
Fly Intel: Top five analyst initiations
08/27/19 H.C. Wainwright
CleanSpark initiated with a Buy at H.C. Wainwright
BLDP Ballard Power
$4.60 /

+0.075 (+1.66%)

07/01/19
Ballard Power downgraded to Sell on valuation at Roth Capital
07/01/19 Roth Capital
Ballard Power downgraded to Sell from Neutral at Roth Capital
11/02/18 B. Riley FBR
Ballard Power downgraded to Neutral from Buy at B. Riley FBR
BDSI BioDelivery Sciences
$4.40 /

+ (+0.00%)

04/16/19 Cantor Fitzgerald
BioDelivery acquisitoin of Symproic a positive, says Cantor Fitzgerald
03/19/19 Truist
BioDelivery Sciences initiated with a Buy at SunTrust
01/31/19
Fly Intel: Top five analyst initiations
01/31/19 Janney Montgomery Scott
BioDelivery Sciences assumed with a Buy at Janney Montgomery Scott
EMBI Emergent Biosolutions
$0.00 /

+ (+0.00%)

HEB Hemispherx
$0.00 /

+ (+0.00%)

08/22/19
Fly Intel: Top five analyst downgrades
08/22/19 Maxim
Hemispherx downgraded to Hold from Buy at Maxim
06/14/19
Fly Intel: Top five analyst initiations
06/14/19 Maxim
Hemispherx initiated with a Buy at Maxim
GTHX G1 Therapeutics
$36.21 /

-0.69 (-1.87%)

08/08/19 JPMorgan
G1 Therapeutics upgraded to Overweight from Neutral at JPMorgan
06/18/19 H.C. Wainwright
G1 Therapeutics trial results 'important,' says H.C. Wainwright
02/07/19 B. Riley FBR
B. Riley FBR starts G1 Therapeutics with Buy rating, $55 price target
02/07/19 B. Riley FBR
G1 Therapeutics initiated with a Buy at B. Riley FBR
KALA Kala Pharmaceuticals
$3.99 /

-0.01 (-0.25%)

06/25/19 Stifel
Evolus can benefit from 'distraction' at Allergan, says Stifel
04/25/19
Oppenheimer initiates Kala with Outperform, sees attractive growth story
04/24/19 Oppenheimer
Kala Pharmaceuticals initiated with an Outperform at Oppenheimer
03/14/19
Fly Intel: Top five analyst initiations
KDMN Kadmon
$2.53 /

+0.05 (+2.02%)

09/06/19 Cantor Fitzgerald
Cantor starts 'under-the-radar' Kadmon with Overweight rating
09/05/19 Cantor Fitzgerald
Kadmon initiated with an Overweight at Cantor Fitzgerald
06/26/19
Fly Intel: Top five analyst initiations
06/26/19
Oppenheimer bullish on Kadmon, initiates with an Outperform
MNKD MannKind
$1.23 /

+0.05 (+4.26%)

05/14/19
Fly Intel: Top five analyst initiations
05/14/19 BTIG
MannKind initiated with a Buy, $3 price target at BTIG
05/08/19 H.C. Wainwright
MannKind price target lowered to $3 from $4 at H.C. Wainwright
03/04/19
Fly Intel: Top five analyst initiations
MNLO Menlo Therapeutics
$4.77 /

-0.18 (-3.64%)

10/09/18 Jefferies
Menlo Therapeutics price target lowered to $7 from $9 at Jefferies
OPNT Opiant Pharmaceuticals
$13.75 /

-0.04 (-0.29%)

05/29/19 Northland
Opiant Pharmaceuticals initiated with an Outperform at Northland
03/22/19 Cantor Fitzgerald
Opiant pipeline remains free at current share levels, says Cantor Fitzgerald
10/26/18
Opiant Pharma initiates patent challenge for Perrigo's generic version of Narcan
09/28/18 Cantor Fitzgerald
Opiant Pharmaceuticals price target raised to $42 from $32 at Cantor Fitzgerald
PRVB Provention Bio
$10.30 /

+0.31 (+3.10%)

08/05/19 SVB Leerink
Provention Bio price target raised to $35 from $17 at SVB Leerink
06/10/19 Chardan
Provention Bio initiated with a Buy at Chardan
02/22/19 SVB Leerink
Provention Bio initiated with an Outperform at SVB Leerink
01/18/19 H.C. Wainwright
Provention Bio initiated with a Buy at H.C. Wainwright
SMTS Sierra Metals
$1.21 /

+ (+0.00%)

UMRX Unum Therapeutics
$2.01 /

+0.17 (+9.24%)

08/13/19 Wedbush
Unum Therapeutics price target lowered to $13 from $20 at Wedbush
07/03/19 H.C. Wainwright
Unum Therapeutics shares overreacted to clinical hold, says H.C. Wainwright
07/03/19 Cowen
Unum Therapeutics clinical hold not an issue, says Cowen
07/03/19 Truist
Unum Therapeutics price target lowered to $6 from $10 at SunTrust
SBBP Strongbridge Biopharma
$2.68 /

+0.055 (+2.10%)

12/18/18 Laidlaw
Strongbridge Biopharma initiated with a Buy at Laidlaw
11/01/18 Stifel
Stifel says Strongbridge makes 'right move' to improve Recorlev clinical package
PHIO Phio Pharmaceuticals
$0.33 /

+0.0075 (+2.34%)

NDRA Endra Life Sciences
$1.79 /

-0.06 (-3.24%)

07/15/19 H.C. Wainwright
Endra Life Sciences initiated with a Buy at H.C. Wainwright
06/13/19
Endra Life Sciences initiated with a Buy at Dougherty
05/20/19 Lake Street
Endra Life Sciences initiated with a Buy at Lake Street
VTVT vTv Therapeutics
$1.35 /

-0.02 (-1.46%)

05/30/19 H.C. Wainwright
vTv Therapeutics initiated with a Buy at H.C. Wainwright
05/06/19 Northland
vTv Therapeutics upgraded to Outperform from Market Perform at Northland
05/06/19 Northland
vTv Therapeutics upgraded to Outperform from Market Perform at Northland
ZYNE Zynerba
$11.72 /

+0.01 (+0.09%)

06/10/19 Piper Sandler
Cannabis regulation could become top 2020 election issue, says Piper Jaffray
05/31/19 Cantor Fitzgerald
Zynerba price target raised to $22 from $12 at Cantor Fitzgerald
05/31/19 H.C. Wainwright
Zynerba remains 'potentially dramatically undervalued,' says H.C. Wainwright
05/08/19
Zynerba reports Q1 EPS (47c), consensus (49c)
ZYXI Zynex
$9.43 /

-0.05 (-0.53%)

06/27/19 B. Riley FBR
Zynex selloff on S-3 filing a buying opportunity, says B. Riley FBR
10/10/18 B. Riley FBR
Zynex initiated with a Buy at B. Riley FBR
VSTM Verastem
$1.23 /

+0.015 (+1.24%)

06/20/19 JonesTrading
JonesTrading downgrades Verastem as CEO marks third major management exit
06/20/19 JonesTrading
Verastem downgraded to Hold from Buy at JonesTrading
06/20/19 BTIG
Verastem downgraded to Neutral from Buy at BTIG
05/14/19 Roth Capital
Verastem price target lowered to $4 from $14 at Roth Capital
THOR Synthorx
$18.89 /

+0.35 (+1.89%)

03/15/19 SVB Leerink
Synthorx initiated with an Outperform at SVB Leerink
01/02/19
Fly Intel: Top five analyst initiations
01/02/19 Jefferies
Jefferies starts Synthorx with Buy rating, $21 price target
01/02/19 H.C. Wainwright
Synthorx initiated with a Buy at H.C. Wainwright
SAVA Cassava Sciences
$1.40 /

+0.13 (+10.24%)

08/01/19
Fly Intel: Top analyst initiations
08/01/19 H.C. Wainwright
Cassava Sciences initiated with a Buy at H.C. Wainwright
06/25/19 Maxim
Cassava Sciences initiated with a Buy at Maxim
06/25/19 Maxim
Cassava Sciences initiated with a Buy at Maxim

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.